Table 10.
No. | Items | B | Exp(B) | P-value | 95% CI for Exp(B) |
---|---|---|---|---|---|
X1 | Age | 0.91 | 2.48 | 0.031 | (1.16, 3.80) |
X2 | BMD | −1.18 | 0.31 | <0.001 | (0.06, 0.56) |
X3 | ODA | −0.97 | 0.38 | 0.001 | (0.11, 0.65) |
X4 | RD | 0.15 | 1.16 | 0.241 | (0.14, 2.18) |
X5 | BCL | 0.22 | 1.25 | 0.506 | (0.31, 2.19) |
X6 | AOT | −0.43 | 0.65 | 0.147 | (0.13, 1.17) |
X0 | Constant | 1.03 | 2.80 | 0.000 | – |
SVCF – secondary vertebral compression fracture; BMD – bone mineral density; ODA – outdoor activity; RD – regional distribution; BCL – bone cement leakage; AOT – anti-osteoporosis treatment. Logit(P)=1.03+0.91X1–1.18X2–0.97X3 [X1=age: age <60 (value: 0), 60≤ age <70 (value: 1), 70≤ age <80 (value: 2), age ≥80 (value: 3); X2=BMD: <20 (value: 0), 20≤ BMD <40 (value: 1), 40≤ BMD <60 (value: 2), 60≤ BMD <80 (value: 3); X3=ODA: low level, <0.5 hour/day (value: 0), medium level, 0.5≤ ODA <2 hour/day (value: 1), high level, ODA ≥2 hour/day (value: 2)].